Overview

Study of Duloxetine Versus Placebo in the Treatment of Fibromyalgia Syndrome

Status:
Completed
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
To assess the efficacy of Duloxetine compared with placebo in the treatment of pain in patients with Fibromyalgia syndrome, with or without major depressive disorder.
Phase:
Phase 3
Details
Lead Sponsor:
Eli Lilly and Company
Collaborator:
Boehringer Ingelheim
Treatments:
Duloxetine Hydrochloride